214273-17-3 Usage
Uses
Used in Medicinal Chemistry:
(2R)-4-(PhenylMethyl)-2-MorpholineMethanamine is used as a compound in medicinal chemistry for its potential to interact with biological targets and exhibit therapeutic effects. Its unique structure and stereochemistry may contribute to its ability to modulate specific biological pathways or bind to receptors, making it a promising candidate for drug development.
Used in Chemical Synthesis:
(2R)-4-(PhenylMethyl)-2-MorpholineMethanamine is used as an intermediate in chemical synthesis for the production of other complex organic compounds. Its versatile structure allows for further functionalization and modification, enabling the synthesis of a wide range of molecules with diverse properties and applications.
Note: The specific applications and properties of (2R)-4-(PhenylMethyl)-2-MorpholineMethanamine are not extensively documented in available resources. However, its unique structure and potential uses in medicinal chemistry and chemical synthesis highlight its importance in the field of organic chemistry. Further research and development may reveal additional applications and insights into its properties and reactivities.
Check Digit Verification of cas no
The CAS Registry Mumber 214273-17-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,4,2,7 and 3 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 214273-17:
(8*2)+(7*1)+(6*4)+(5*2)+(4*7)+(3*3)+(2*1)+(1*7)=103
103 % 10 = 3
So 214273-17-3 is a valid CAS Registry Number.
214273-17-3Relevant academic research and scientific papers
DIHYDROPTERIDINONE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF
-
Page/Page column 47, (2012/08/08)
Dihydroperidinone derivatives, preparation process and pharmaceutical use thereof are disclosed. Specially, new dihydroperidinone derivatives represented by general formula (I), wherein each substituent of the general formula (I) is defined as in the description, their preparation process, pharmaceutical compositions comprising said derivatives and their use as therapeutical agents, especially as Plk kinase inhibitors are disclosed.
DIHYDROPTERIDINONE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF
-
Page/Page column 48-49, (2012/07/28)
Dihydroperidinone derivatives, preparation process and pharmaceutical use thereof are disclosed. Specially, new dihydroperidinone derivatives represented by general formula (I), wherein each substituent of the general formula (I) is defined as in the description, their preparation process, pharmaceutical compositions comprising said derivatives and their use as therapeutical agents, especially as Plk kinase inhibitors are disclosed.
